View source for Chemistry:Ortataxel

{{Drugbox
| Watchedfields = changed
| verifiedrevid = 444426587
| IUPAC_name = (3a''S'',4''R'',7''R'',8a''S'',9''S'',10a''R'',12a''S'',13''S'',13a''S'')-7,12a-bis(acetyloxy)-4-({(2''R'',3''S'')-3-[''tert''-butoxycarbonyl)amino]-2-hydroxy-5-methylhexanoyl}oxy)-9-hydroxy-5,8a,14,14-tetramethyl-2,8-dioxo-3a,4,7,8,8a,9,10,10a,12,12a,12b,13-dodecahydro-6,13a-methano[1,3]dioxolo[8,9]cyclodeca[1,2-''d''][1]benzoxet-13-yl benzoate
| image = Ortataxel.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 186348-23-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 10557575
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 8H61Y4E29N
| ChemSpiderID = 5293609

<!--Chemical data-->
| C=44 | H=57 | N=1 | O=17 
| smiles = CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@]5(C2(C)C)[C@H]([C@@H]1OC(=O)[C@@H]([C@H](CC(C)C)NC(=O)OC(C)(C)C)O)OC(=O)O5)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)OC(=O)C
| StdInChI = 1S/C44H57NO17/c1-20(2)17-25(45-38(53)61-40(6,7)8)29(49)37(52)57-30-21(3)28-31(56-22(4)46)33(50)42(11)26(48)18-27-43(19-55-27,60-23(5)47)32(42)35(58-36(51)24-15-13-12-14-16-24)44(41(28,9)10)34(30)59-39(54)62-44/h12-16,20,25-27,29-32,34-35,48-49H,17-19H2,1-11H3,(H,45,53)/t25-,26-,27+,29+,30+,31+,32-,34-,35-,42+,43-,44+/m0/s1
| StdInChIKey = BWKDAMBGCPRVPI-ZQRPHVBESA-N
}}

'''Ortataxel''' is a drug used in [[Medicine:Chemotherapy|chemotherapy]].
{{as of|June 2009}}, [[Company:Spectrum Pharmaceuticals|Spectrum Pharmaceuticals]] has the drug in a Phase 2 [[Engineering:Clinical trial|clinical trial]]. 


{{Chemotherapeutic agents}}


[[Category:Benzoate esters]]
[[Category:Carbamates]]
[[Category:Secondary alcohols]]
[[Category:Lactones]]
[[Category:Acetate esters]]
[[Category:Taxanes]]



{{Unreferenced|date=2021}}
{{Sourceattribution|Ortataxel}}